Neuroactive steroids in the developing brain: potential for preventing perinatal brain damage

大脑发育中的神经活性类固醇:预防围产期脑损伤的潜力

基本信息

  • 批准号:
    nhmrc : 284239
  • 负责人:
  • 金额:
    $ 32.11万
  • 依托单位:
  • 依托单位国家:
    澳大利亚
  • 项目类别:
    NHMRC Project Grants
  • 财政年份:
    2004
  • 资助国家:
    澳大利亚
  • 起止时间:
    2004-01-01 至 2006-12-31
  • 项目状态:
    已结题

项目摘要

Complications during pregnancy, birth asphyxia or premature birth can lead to serious neurological impairment in the newborn. Despite excellent neonatal care many of these babies go on to have serious handicaps. Neuroactive steroids are a group of neuromodulators that are derived from the hormone progesterone. These steroids fall into two groups, those that appear to protect brain cells from damage caused by an inadequate supply of oxygen and those that may increase cell death. We have shown that protective neuroactive steroids are present in very large amounts in the fetal brain. Steroids produced by the placenta are converted to these neuroactive products by enzymes in the brain leading to the high levels that are seen during fetal life. Certain adverse conditions during pregnancy as well as preterm birth may cause marked changes in the balance of steroids that could increase susceptibility to brain injury. We have found that areas of the brain, where damage most often occurs, normally contain the highest amount of protective steroids, but only in late pregnancy. This suggests that disturbances that lower steroid production in these areas could contribute to the death of cells, particularly in mid-pregnancy and after premature birth. In the proposed studies, we will examine whether a toxic balance of steroids develops following adverse events in pregnancy as well as the areas of the brain where this is most pronounced. We will examine the changes in the expression of enzymes that can potentially cause the accumulation of protective steroids in the brain. We will then examine treatments that can raise the concentration of steroids and determine which combination of steroids best reduces cell death and brain injury following complications during pregnancy. The findings of this work will indicate the best therapeutic approach that may be adopted to modify the concentration of certain steroids so as to reduce the risk of brain damage in the fetus and neonate.
怀孕期间的并发症、出生窒息或早产可导致新生儿严重的神经功能障碍。尽管新生儿得到了很好的护理,但这些婴儿中的许多人仍然有严重的残疾。神经活性类固醇是一组神经调质,来源于激素孕酮。这些类固醇分为两类,一类似乎可以保护脑细胞免受氧气供应不足造成的损伤,另一类可能会增加细胞死亡。我们已经表明,保护性神经活性类固醇是目前在非常大量的胎儿大脑。由胎盘产生的类固醇通过大脑中的酶转化为这些神经活性产物,导致在胎儿生命期间看到的高水平。怀孕期间的某些不利条件以及早产可能会导致类固醇平衡的显着变化,这可能会增加对脑损伤的敏感性。我们发现,大脑中最常发生损伤的区域通常含有最高量的保护性类固醇,但仅在怀孕后期。这表明,这些区域类固醇产生减少的干扰可能导致细胞死亡,特别是在怀孕中期和早产后。在拟议的研究中,我们将检查类固醇的毒性平衡是否在妊娠不良事件后发展,以及大脑中最明显的区域。我们将研究可能导致保护性类固醇在大脑中积累的酶表达的变化。然后,我们将研究可以提高类固醇浓度的治疗方法,并确定哪种类固醇组合最能减少怀孕期间并发症后的细胞死亡和脑损伤。这项工作的结果将表明最好的治疗方法,可以采取改变某些类固醇的浓度,以减少胎儿和新生儿脑损伤的风险。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jonathan Hirst其他文献

Jonathan Hirst的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jonathan Hirst', 18)}}的其他基金

DichroCalc: DNA Dichroism Calculations
DichroCalc:DNA 二色性计算
  • 批准号:
    BB/H023674/1
  • 财政年份:
    2010
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Research Grant
Sustainable domain-specific software generation tools for extremely parallel particle-based simulations
可持续的特定领域软件生成工具,用于极其并行的基于粒子的模拟
  • 批准号:
    EP/I006559/1
  • 财政年份:
    2010
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Research Grant
Photochemistry in the Membrane: Quantum Chemical Studies of Fluorophores In Situ
膜中的光化学:荧光团原位的量子化学研究
  • 批准号:
    EP/F006780/1
  • 财政年份:
    2007
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Research Grant
Essential protective role of neuroactive steroids in the fetal and neonatal brain.
神经活性类固醇对胎儿和新生儿大脑的重要保护作用。
  • 批准号:
    nhmrc : 143503
  • 财政年份:
    2001
  • 资助金额:
    $ 32.11万
  • 项目类别:
    NHMRC Project Grants
Neuroactive steroids in the fetal brain: role in the regulation of behaviour and protection against hypoxia
胎儿大脑中的神经活性类固醇:在行为调节和缺氧保护中的作用
  • 批准号:
    nhmrc : 124457
  • 财政年份:
    2000
  • 资助金额:
    $ 32.11万
  • 项目类别:
    NHMRC Project Grants
Theoretical Studies of the Circular Dichroism of Peptides and Proteins
肽和蛋白质圆二色性的理论研究
  • 批准号:
    9632124
  • 财政年份:
    1996
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Standard Grant

相似海外基金

Developing novel therapies to improve blood stem cell transplantation outcomes
开发新疗法以改善造血干细胞移植结果
  • 批准号:
    10830194
  • 财政年份:
    2023
  • 资助金额:
    $ 32.11万
  • 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
  • 批准号:
    10586562
  • 财政年份:
    2023
  • 资助金额:
    $ 32.11万
  • 项目类别:
Developing novel therapies to improve blood stem cell transplantation outcomes
开发新疗法以改善造血干细胞移植结果
  • 批准号:
    10458315
  • 财政年份:
    2022
  • 资助金额:
    $ 32.11万
  • 项目类别:
The role of a pleiotropic drug resistance (PDR) transporter in the cryptococcal-host interactions
多效性耐药(PDR)转运蛋白在隐球菌-宿主相互作用中的作用
  • 批准号:
    10593492
  • 财政年份:
    2022
  • 资助金额:
    $ 32.11万
  • 项目类别:
Developing and commercialising a non-invasive test of adrenal insufficiency for children on steroids.
开发并商业化针对使用类固醇的儿童肾上腺功能不全的非侵入性测试。
  • 批准号:
    MR/W002795/1
  • 财政年份:
    2021
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Research Grant
Developing polycistronic replication-defective herpes simplex virus vectors as immunotherapeutic tools for treating melanoma
开发多顺反子复制缺陷型单纯疱疹病毒载体作为治疗黑色素瘤的免疫治疗工具
  • 批准号:
    10057822
  • 财政年份:
    2020
  • 资助金额:
    $ 32.11万
  • 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
  • 批准号:
    10457913
  • 财政年份:
    2019
  • 资助金额:
    $ 32.11万
  • 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
  • 批准号:
    10222699
  • 财政年份:
    2019
  • 资助金额:
    $ 32.11万
  • 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
  • 批准号:
    10666415
  • 财政年份:
    2019
  • 资助金额:
    $ 32.11万
  • 项目类别:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
类固醇和交联治疗溃疡 (SCUT II)
  • 批准号:
    10167111
  • 财政年份:
    2019
  • 资助金额:
    $ 32.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了